Back to companies
GYRE THERAPEUTICS, INC.
GYREUSNASDAQPharmaceuticals & HealthcareGYRE THERAPEUTICS, INC.
Revenue
$116.6mn
YoY +10.2%
Operating income
$11.5mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API